Literature DB >> 27926437

Involvement of opioid signaling in food preference and motivation: Studies in laboratory animals.

I Morales1, L Font2, P J Currie1, R Pastor3.   

Abstract

Motivation is a complex neurobiological process that initiates, directs, and maintains goal-oriented behavior. Although distinct components of motivated behavior are difficult to investigate, appetitive and consummatory phases of motivation are experimentally separable. Different neurotransmitter systems, particularly the mesolimbic dopaminergic system, have been associated with food motivation. Over the last two decades, however, research focusing on the role of opioid signaling has been particularly growing in this area. Opioid receptors seem to be involved, via neuroanatomically distinct mechanisms, in both appetitive and consummatory aspects of food reward. In the present chapter, we review the pharmacology and functional neuroanatomy of opioid receptors and their endogenous ligands, in the context of food reinforcement. We examine literature aimed at the development of laboratory animal techniques to better understand different components of motivated behavior. We present recent data investigating the effect of opioid receptor antagonists on food preference and effort-related decision making in rats, which indicate that opioid signaling blockade selectively affects intake of relatively preferred foods, resulting in reduced willingness to exert effort to obtain them. Finally, we elaborate on the potential role of opioid system manipulations in disorders associated with excessive eating and obesity.
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Decision making; Eating disorders; Effort; Food preference; Motivation; Opioid system

Mesh:

Substances:

Year:  2016        PMID: 27926437     DOI: 10.1016/bs.pbr.2016.06.002

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  4 in total

1.  Noradrenaline transporter availability on [11C]MRB PET predicts weight loss success in highly obese adults.

Authors:  Franziska J Vettermann; Michael Rullmann; Georg A Becker; Julia Luthardt; Franziska Zientek; Marianne Patt; Philipp M Meyer; Anke McLeod; Matthias Brendel; Matthias Blüher; Michael Stumvoll; Anja Hilbert; Yu-Shin Ding; Osama Sabri; Swen Hesse
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-07       Impact factor: 9.236

Review 2.  Opioid modulation of cognitive impairment in depression.

Authors:  Moriah L Jacobson; Hildegard A Wulf; Caroline A Browne; Irwin Lucki
Journal:  Prog Brain Res       Date:  2018-09-18       Impact factor: 2.453

3.  The Paraventricular Hypothalamus Regulates Satiety and Prevents Obesity via Two Genetically Distinct Circuits.

Authors:  Monica M Li; Joseph C Madara; Jennifer S Steger; Michael J Krashes; Nina Balthasar; John N Campbell; Jon M Resch; Nicholas J Conley; Alastair S Garfield; Bradford B Lowell
Journal:  Neuron       Date:  2019-03-14       Impact factor: 17.173

4.  Pharmacological investigations of effort-based decision-making in humans: Naltrexone and nicotine.

Authors:  Cecilia Nunez; Jennifer K Hoots; Scott T Schepers; Michael Bower; Harriet de Wit; Margaret C Wardle
Journal:  PLoS One       Date:  2022-10-05       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.